These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

921 related items for PubMed ID: 17097453

  • 1. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B.
    Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
    [Abstract] [Full Text] [Related]

  • 2. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
    Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M.
    J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
    [Abstract] [Full Text] [Related]

  • 3. Healthcare workers and immunity to infectious diseases.
    Vagholkar S, Ng J, Chan RC, Bunker JM, Zwar NA.
    Aust N Z J Public Health; 2008 Aug; 32(4):367-71. PubMed ID: 18782402
    [Abstract] [Full Text] [Related]

  • 4. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad.
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [Abstract] [Full Text] [Related]

  • 5. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ, Robertson PW, Whybin LR.
    Med J Aust; 1994 Apr 18; 160(8):478-82. PubMed ID: 8170422
    [Abstract] [Full Text] [Related]

  • 6. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A.
    An Esp Pediatr; 1999 May 18; 50(5):459-62. PubMed ID: 10394183
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
    Hatakeyama S, Moriya K, Itoyama S, Nukui Y, Uchida M, Shintani Y, Morisawa Y, Kimura S.
    Infect Control Hosp Epidemiol; 2004 Jul 18; 25(7):591-4. PubMed ID: 15301032
    [Abstract] [Full Text] [Related]

  • 8. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
    Llenas-García J, Rubio R, Hernando A, Arrazola P, Pulido F.
    AIDS Care; 2013 Aug 18; 25(8):980-9. PubMed ID: 23244745
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb 18; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.
    Pediatr Infect Dis J; 2008 Aug 18; 27(8):724-30. PubMed ID: 18600190
    [Abstract] [Full Text] [Related]

  • 11. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J, da Cunha S, Côrte-Real R, Sampaio L, Dais N, Meliço-Silvestre A.
    Acta Med Port; 1995 Apr 18; 8(4):206-16. PubMed ID: 7625214
    [Abstract] [Full Text] [Related]

  • 12. [The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas].
    Oliveira J, Dias N, Ferreira TM, da Cunha S, Costa D, Côrte-Real R, Meliço-Silvestre A.
    Acta Med Port; 1999 Apr 18; 12(4-6):155-60. PubMed ID: 10481316
    [Abstract] [Full Text] [Related]

  • 13. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.
    Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M.
    Infect Control Hosp Epidemiol; 2006 Nov 18; 27(11):1178-83. PubMed ID: 17080374
    [Abstract] [Full Text] [Related]

  • 14. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, Douha M, Willems P.
    Eur J Pediatr; 2012 Mar 18; 171(3):463-70. PubMed ID: 21935584
    [Abstract] [Full Text] [Related]

  • 15. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA.
    Pediatrics; 1986 Oct 18; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence of measles, mumps, rubella and varicella among staff of a hospital in Riyadh, Saudi Arabia.
    Abbas M, Atwa M, Emara A.
    J Egypt Public Health Assoc; 2007 Oct 18; 82(3-4):283-97. PubMed ID: 18410713
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y, Steri GC, Behre U, Arsène JP, Lanse X, Helm K, Esposito S, Meister N, Desole MG, Douha M, Willems P.
    Vaccine; 2009 Jan 14; 27(3):446-53. PubMed ID: 19007835
    [Abstract] [Full Text] [Related]

  • 18. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H, Tokuda K, Ikeda S, Endo S, Ishizawa C, Hirai Y, Takahashi M, Aoyagi T, Hatta M, Gu Y, Yano H, Weber DJ, Kaku M.
    Tohoku J Exp Med; 2014 Oct 14; 234(2):111-6. PubMed ID: 25224029
    [Abstract] [Full Text] [Related]

  • 19. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML, Martínez D, Santos-Sancho JM, Borda JR, Orero A.
    Rev Esp Quimioter; 2014 Jun 14; 27(2):98-101. PubMed ID: 24940889
    [Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P, Lim FS, Han HH, Willems P.
    Infection; 2007 Oct 14; 35(5):326-33. PubMed ID: 17710370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.